Drugs for Neglected Diseases initiative (DNDi), Genève, GE | Swiss Graph

Drugs for Neglected Diseases initiative (DNDi)

ActiveFoundation721001 - Research and experimental development in the pharmaceutical industry

Enriching this profile

Discovering products, team, contacts and branding from the company's website. The page updates automatically when ready.

At a glance

Drugs for Neglected Diseases initiative (DNDi) is a Swiss Stiftung registered in Genève, GE. Its registered activity falls under Research and experimental development in the pharmaceutical industry.

AI Insight

Registry narrative generated from SHAB/SOGC facts.

Officers95Active Relations34Deleted Relations0SOGC Records67First Record11.07.2003Latest Activity05.06.2026

Registry Information

3 additional addresses

Swiss UID: CHE-110.141.200
Legal Name: Drugs for Neglected Diseases initiative (DNDi)
Legal Form: Foundation
Incorporated: 11 Jul 2003
Canton: GE
Status: Active
Country: Switzerland

Company Purpose

Translating…

NOGA Codes

(Industry classification)

721001Research and experimental development in the pharmaceutical industry

NPROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES72Scientific research and development721Research and experimental development on natural sciences and engineering7210Research and experimental development on natural sciences and engineering721001

Industry Health

Registered Address

chemin Camille-Vidart 15, 1202 Genève

1202, Genève, GE

Companies at this address

Enrich from integrations

Pull data from your connected providers and merge it with the registry.

Registry Pulse

Registry pulse is a Pro feature

Auditor

Has auditor

PricewaterhouseCoopers SA

Since

Current Directors & Officers